Colorectal Cancer
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2006; 12(38): 6128-6132
Published online Oct 14, 2006. doi: 10.3748/wjg.v12.i38.6128
Table 1 Characteristics of control subjects and cancer patients
GroupSex (M/F)Mean age ± SD (yr)(range)TNM staging
Controls100 (56/44)64 ± 6 (46-79)//
Cancer patients93 (51/42)62 ± 8 (48-78)T1-3, N0-2, M0
Table 2 tHcy plasma levels according to C677T MTHFR polymorphism [mean ± SD (μmol/L) (n)]
Group (n)CC genotypeCT genotypeTT genotype
Control subjects (100)9.01 ± 2.76 (30)9.71 ± 2.34 (51)17.56 ± 10.81df (19)
Cancer patients (93)11.82 ± 3.09a (32)12.45 ± 4.46b (40)16.88 ± 9.25 df (21)
Table 3 tHcy plasma levels according to CC + CT genotype of C677T MTHFR polymorphism [mean ± SD (μmol/L) (n)]
Group(CC+CT) genotype
Control subjects9.45 ± 2.51 (81)
Cancer patients12.17 ± 3.90b (72)